Günther Loidl
Chief Tech/Sci/R&D Officer chez BACHEM HOLDING AG
Fortune : 1 M $ au 30/04/2024
Postes actifs de Günther Loidl
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BACHEM HOLDING AG | Chief Tech/Sci/R&D Officer | 01/01/2015 | - |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Director/Board Member | 01/01/2000 | - |
Historique de carrière de Günther Loidl
Formation de Günther Loidl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistiques
Internationale
| Suisse | 3 |
| Allemagne | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
- Bourse
- Insiders
- Günther Loidl
- Expérience
